UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

Frontiers in immunology, 2018-04, Vol.9, p.557-557

Pranzatelli, Michael R

2018

Link zum Volltext

Verfügbarkeit prüfen

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

Frontiers in neurology, 2017-09, Vol.8, p.468-468

2017

Link zum Volltext

Verfügbarkeit prüfen

Elevated cerebrospinal fluid C-X-C motif chemokine 10: Commonalities in paraneoplastic neurological disorders

Annals of neurology, 2016-11, Vol.80 (5), p.792-793

Pranzatelli, Michael R.

2016

Link zum Volltext

Verfügbarkeit prüfen

Response to Correspondence on “Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome”

Journal of Child Neurology, 2013-03, Vol.28 (3), p.417-418

2013

Link zum Volltext

Verfügbarkeit prüfen

Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping

Seminars in pediatric neurology, 2017-08, Vol.24 (3), p.229-239

2017

Link zum Volltext

Verfügbarkeit prüfen

Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS

Journal of neuroimmunology, 2018-08, Vol.321, p.150-156

2018

Link zum Volltext

Verfügbarkeit prüfen

Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers

Cytokine (Philadelphia, Pa.), 2017-08, Vol.96, p.49-53

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome” [Pediatric Neurology 73 (2017) 48–56]

Pediatric neurology, 2018-01, Vol.78, p.84-84

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to Sharawat and Suther

Pediatric neurology, 2018-01, Vol.78, p.e3-e3

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome

Pediatric neurology, 2018-08, Vol.85, p.71-75

2018

Link zum Volltext

Verfügbarkeit prüfen

Going with the flow: neuroinflammation

Developmental medicine and child neurology, 2011-09, Vol.53 (9), p.782-782

PRANZATELLI, MICHAEL R

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study

European journal of paediatric neurology, 2018-07, Vol.22 (4), p.586-594

2018

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS” [Cytokine 53 (2011) 384–389]

Cytokine (Philadelphia, Pa.), 2017-06, Vol.94, p.60-60

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Journal of Child Neurology, 2011-11, Vol.26 (11), p.1411-1421

2011

Link zum Volltext

Verfügbarkeit prüfen

Paraneoplastic movement disorders in childhood

Movement disorders, 2014-02, Vol.29 (2), p.281-281

2014

Link zum Volltext

Verfügbarkeit prüfen

Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma

Neurology : neuroimmunology & neuroinflammation, 2018-03, Vol.5 (2), p.e433-e433

2018

Link zum Volltext

Verfügbarkeit prüfen

Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus

Pediatric blood & cancer, 2012-06, Vol.58 (6), p.988-991

2012

Link zum Volltext

Verfügbarkeit prüfen

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

Child neurology open, 2018, Vol.5, p.2329048X18795546

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS

Cytokine (Philadelphia, Pa.), 2011-03, Vol.53 (3), p.384-389

2011

Link zum Volltext

Verfügbarkeit prüfen

An unusual presentation of anti‐Hu‐associated paraneoplastic limbic encephalitis

Developmental medicine and child neurology, 2012-09, Vol.54 (9), p.863-866

2012

Link zum Volltext

Verfügbarkeit prüfen

Acquired ataxias, infectious and para-infectious

Handbook of Clinical Neurology, 2012, Vol.103, p.137-146

2012

Link zum Volltext

Verfügbarkeit prüfen

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome

Journal of pediatric hematology/oncology, 2006-09, Vol.28 (9), p.585-593

2006

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus

Neurology : neuroimmunology & neuroinflammation, 2017-03, Vol.4 (2), p.e316-e316

2017

Link zum Volltext

Verfügbarkeit prüfen

Introduction

Seminars in pediatric neurology, 2017-08, Vol.24 (3), p.143-144

Pranzatelli, Michael R.

2017

Link zum Volltext

Verfügbarkeit prüfen

Promise, Progress, and Pitfalls in the Search for CNS Biomarkers in Neuroimmunological Diseases: A Role for CSF Immunophenotyping

Seminars in pediatric neurology, 2017-08, Vol.24 (3), p.229-239

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

ThemaChild, Preschool

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Humans
(41)
Neurosciences & Neurology
(40)
Animals
(34)
Male
(34)
Biological And Medical Sciences
(32)
Clinical Neurology
(28)
Rats
(27)
Medical Sciences
(23)
Pediatrics
(20)
Neurosciences
(18)
Rats, Inbred Strains
(18)
Child
(17)
Myoclonus
(17)
Pharmacology & Pharmacy
(17)
Receptors, Serotonin - Drug Effects
(16)
Pharmacology. Drug Treatments
(15)
Neurology
(14)
Female
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

Demographic, Clinical, and Immunologic Features of 389 Children with Opsoclonus-Myoclonus Syndrome: A Cross-sectional Study

Elevated cerebrospinal fluid C-X-C motif chemokine 10: Commonalities in paraneoplastic neurological disorders

Response to Correspondence on “Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome”

Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping

Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS

Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers

Corrigendum to “Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome” [Pediatric Neurology 73 (2017) 48–56]

Response to Sharawat and Suther

Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome

Going with the flow: neuroinflammation

Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study

Corrigendum to “Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS” [Cytokine 53 (2011) 384–389]

Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives

Paraneoplastic movement disorders in childhood

Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma

Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus

Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies

Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS

An unusual presentation of anti‐Hu‐associated paraneoplastic limbic encephalitis

Acquired ataxias, infectious and para-infectious

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome

Characteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupus

Introduction

Promise, Progress, and Pitfalls in the Search for CNS Biomarkers in Neuroimmunological Diseases: A Role for CSF Immunophenotyping

Aktive Filter

Suchergebnisse filtern